Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from OFS

Zetwerk’s promoters have pledged nearly a third of their combined stake, IPO prospectus shows

Founders Srinath Ramakkrushnan and Amrit Acharya have pledged 1.85% of the company's equity directly.

The Economic Times

Shiprocket IPO ends day 3 with 99.3x subscription on strong QIB push. Check GMP & other details

Shiprocket’s IPO was subscribed 99.31 times, led by strong institutional demand, with QIBs subscribing 122.8 times. The Rs 1,617.59 crore issue also commands a 38% grey market premium over the upper price band of Rs 97. Analysts have recommended subscribing, citing the company’s growth prospects, scalable model and e-commerce opportunity.

The Economic Times

Milky Mist Dairy Food IPO Day 3: GMP signals to 15% listing upside — Should you subscribe?

Milky Mist IPO GMP: Given the company’s growth prospects and positioning, Anand Rathi has assigned a “Subscribe – Long Term” rating to the IPO, suggesting that investors may consider the issue from a longer-term perspective rather than focusing solely on potential listing gains.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as many as 70 times bids overall for its Rs 939 crore issue, with QIBs bidding 180 times the shares on offer.

The Economic Times

Shiprocket IPO opens for subscription. Should you apply for Temasek, Eternal-backed issue?

Shiprocket IPO GMP: In the grey market, Shiprocket shares are currently commanding a 31% premium over the upper end of the issue price of Rs 97, signalling expectations of a strong listing gain.

The Economic Times

Tablespace technologies files draft papers with Sebi to raise funds through IPO

Tablespace Technologies has filed its DRHP with SEBI for an IPO comprising a fresh issue of up to ₹800 crore and an OFS. The managed workspace provider plans to repay borrowings, pursue acquisitions and fund corporate needs.

The Economic Times

Sunshine Pictures IPO price band set at ₹342-360; issue opens on August 18

Sunshine Pictures’ IPO opens August 18, 2026, closing August 20. The price band is set at ₹342-360, with a lot size of 41 shares. The company aims to raise ₹282.14 crore to fund working capital and general corporate needs.

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GMP) climbed to 17% from 15% earlier. The issue was subscribed 83% on Day 1, with retail investors subscribing to 77% of their quota. The Rs 939.70-crore IPO comprises…

The Economic Times

Milky Mist Dairy Food IPO Day 1: Subscribed 40% so far, GMP signals 15% listing gain. Should you subscribe?

On August 11, 2026, Milky Mist Dairy Food launched its IPO, which saw an enthusiastic 41% subscription on the opening day, reflecting significant retail interest. A notable 15% grey market premium hints at favorable listing gains for investors. The revenue from the IPO will be directed towards settling debts and…

The Economic Times

Milky Mist Dairy Food IPO set to open, GMP signals 20% listing gain. Check price band, lot size and key dates

Milky Mist Dairy Food IPO opens on August 11 and closes on August 13, with the Rs 1,553 crore issue priced at Rs 133-140 per share. The latest GMP of Rs 26 signals a potential 19% listing gain, while investors can check the lot size, key dates and IPO details…

The Economic Times

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E multiple of 64.9x for its listed peers, according to analysts.

The Economic Times

Dhoot Transmission's Rs 3,067 crore IPO opens for subscription; GMP signals 30% listing gains. Should you bid?

The IPO comprises a fresh issue of 1.61 crore equity shares worth Rs 1,400 crore, along with an Offer for Sale (OFS) of 1.91 crore shares aggregating to Rs 1,666.89 crore. Under the OFS, BC Asia Investments XV Ltd. will offload shares worth nearly Rs 1,395 crore, while Mangalam Capital…

The Economic Times

LIC sees no further government stake sale for 18-24 months, says MD; Q1 profit rises 23%

The government will likely not sell more LIC shares for eighteen to twenty-four months. LIC has until 2032 to meet minimum public shareholding norms. The company recently saw a 6.5 percent stake sale well received by markets. LIC achieved ten percent public float ahead of its May 2027 deadline. The…

The Economic Times

LIC shares fall after India’s largest OFS closes with oversubscription on both days

The government raised Rs 31,552 crore through LIC’s record Offer for Sale (OFS), selling a 6.5% stake after exercising the greenshoe option. The issue was oversubscribed, driven by strong retail and institutional demand. The stake sale helped LIC achieve the 10% public shareholding norm ahead of Sebi’s May 2027 deadline,…

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Shiprocket IPO price band fixed at Rs 92-97; Rs 1,618 crore issue to open on August 12

Shiprocket is set to launch its Rs 1,617.59 crore IPO on August 12, 2026, with a price band of Rs 92 to Rs 97 per share. The issue closes on August 14. Net proceeds will be deployed toward technology enhancement, marketing, debt repayment, and strategic growth initiatives.

The Economic Times

LIC OFS gets strong response from retail investors, subscribed 1.82 times the base size

LIC’s retail offer for sale attracted strong investor interest, with the base retail issue subscribed 1.82 times. The government’s 6.5% stake sale follows robust institutional demand and will help the insurer move closer to Sebi’s minimum public shareholding requirement.

The Economic Times

Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807

Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue comprises a fresh issue of Rs 200 crore and an offer for sale (OFS) of Rs 739.70 crore by existing shareholders. The molecular…

The Economic Times

LIC OFS opens for retail investors: Should you apply in insurance behemoth's offer?

The OFS opened for non-retail investors on August 4, and saw strong participation. The offer was oversubscribed more than 3 times its offer size. It now opens for retail investors today.

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

LIC OFS: Non-retail portion fully subscribed on Day 1. Here’s what investors should know

LIC's Rs 31,410-crore offer for sale (OFS) was fully booked on Tuesday on Day 1. The government aims to pare its stake through a 2.5% base offer, with an additional 4% green shoe option, while retail investors can bid on August 5.

The Economic Times

LIC shares sink 9% as OFS opens at 11% discount. Here's all you need to know

LIC shares plunged nearly 9% after the government’s offer for sale (OFS) to divest up to a 6.5% stake in the insurer opened for institutional investors. The OFS includes a 2.5% base offer and a 4% green shoe option, with a floor price of Rs 382 per share, an 11%…

The Economic Times

LIC OFS opens on August 4 as govt looks to sell up to 6.5% stake. Check details

The government will launch LIC’s offer for sale for non-retail investors on Tuesday and retail investors on Wednesday. It plans to divest up to 6.5% through a base 2.5% offer and green shoe option, advancing minimum public shareholding compliance.

The Economic Times

KKR-backed LEAP India's IPO opens on August 7; price band set at Rs 151-159

KKR-backed LEAP India will open its Rs 2,480 crore IPO for subscription on August 7, with a price band of Rs 151-159 per share. The issue comprises a Rs 480 crore fresh issue and a Rs 2,000 crore OFS. The company plans to use proceeds to repay debt and for…

The Economic Times

Manipal Health Enterprises IPO: GMP hints at 10% listing gains; know important dates, other details

Manipal Health Enterprises, backed by Temasek and Ranjan Pai, will open its Rs 9,275-crore IPO for subscription on July 29 at a price band of Rs 560-590 per share. The issue comprises a fresh issue of Rs 8,000 crore and an OFS worth Rs 1,275.2 crore. The Bengaluru-based hospital chain…

The Economic Times

Manipal Health Enterprises sets price band for Rs 9,275 crore IPO, opens July 29

Manipal Health Enterprises will launch its Rs 9,275 crore IPO on July 29 with a price band of Rs 560-590 per share. The issue comprises a fresh issue of Rs 8,000 crore and an OFS worth Rs 1,275.2 crore, with proceeds primarily earmarked for debt repayment and acquiring a minority…

The Economic Times

Lohia Corp's Rs 1,100 crore IPO opens for subscription. Check GMP, issue size & other key details

The IPO is entirely an Offer for Sale (OFS) comprising more than 2.59 crore equity shares, which means the proceeds will go to the existing shareholders, while the company itself will not receive any funds from the offering.

1 2 3 4 5

People

Anand Rathi

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Life Insurance Corporation of India

24 stories

Shiprocket

17 stories

Manipal Health Enterprises

Milky Mist Dairy Food

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.